Effect of bone marrow transplantation on the immunolocalization of p53, hMSH2, and hMLH1 proteins on oral mucosa

Oral Diseases

Volumn 10, Issue 4, 2004, Pages 207-211

  Santiago Gomez, Ricardo ^a   Pimenta, F J G S ^a   Guimaraes A L S ^a   Souza, L N ^a   Salomao U E ^a   De Almeida, H C ^a   Vaz, R R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

BMT; HMSH1; HMSH2; Immunohistochemistry; Oral mucosa; P53

Indexed keywords

BIOTIN; DNA; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; STREPTAVIDIN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; LIP BIOPSY; MALE; MISMATCH REPAIR; MOUTH MUCOSA; MUCOCELE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCHOOL CHILD;

ADOLESCENT; BASE PAIR MISMATCH; BONE MARROW TRANSPLANTATION; CARRIER PROTEINS; CASE-CONTROL STUDIES; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOUTH MUCOSA; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3042714780     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2004.01026.x     Document Type: Article

References (31)

1. Abdelsayed RA, Sumner T, Allen CM et al (2002). Oral precancerous and malignant lesions associated with graft-versus-host disease: report of 2 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Oral Endod 93: 75-80.
2. Acharya S, Wilson T, Gradia S et al (1996). hMSH2 forms specific mispairs-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci USA 93: 13629-13634.
3. Bellacosa A, Cicchilliti L, Schepis F et al (1999). MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci USA 96: 3969-3974.
4. Boivin JF, Hutchison GB, Zauber AG (1995). Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 85: 732-741.
5. Bortin MM, Rimm AA (1989). Increasing utilization of bone marrow transplantation II: results of the 1985-1987 survey. Transplantation 48: 453-458.
6. Cox LS (1997). Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. J Pathol 183: 134-140.
7. Curtis RE, Rowlings PA, Deeg HJ et al (1997). Solid cancers after bone marrow transplantation. New Engl J Med 336: 897-904.
8. Deeg HG, Witherspoon RP (1993). Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin North Am 7: 417-429.
9. Deeg HG, Sanders J, Martin P et al (1984). Secondary malignancies after marrow transplantation. Exp Hematol 12: 660-666.
10. Deeg HG, Socie G, Schoch G et al (1996). Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 87: 386-392.
11. Donato V, Iacari V, Zurlo A et al (1998). Fractionated total body irradiation in allogenic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients. Radiother Oncol 48: 267-276.
12. Dowell SP, Ogden GR (1996). The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa: a cautionary note. J Oral Pathol Med 25: 60-64.
13. Gomez RS, Carneiro MA, Souza LN et al (2001). Oral recurrent human herpes virus infection and bone marrow transplantation survival. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 552-556.
14. Jansisyanont P, Pazoki A, Ord RA (2000). Squamous cell carcinoma of the tongue after bone marrow transplantation in a patient with Fanconi's Anemia. J Oral Maxillofac Surg 58: 1454-1457.
15. Kolodner R (1996). Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev 15: 1433-1442.
16. Levine AJ, Momand J, Finlay CA (1991). The p53 tumour supressor gene. Nature 351: 453-456.
17. Lishner M, Patterson B, Kandel R et al (1990). Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer 65: 473-476.
18. Liu K, Huang H, Mukunyadzi P et al (2002). Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 126: 548-553.
19. Lum LG, Seigneuret MC, Storb RF et al (1981). In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. Blood 58: 431-439.
20. Modrich P, Lahuer R (1996). Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Ann Rev Biochem 65: 101-133.
21. Nakamura S, Hiroki A, Shinohara M et al (1996). Oral involvement in chronic graft-versus-host disease after allogenic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Oral Endod 82: 556-563.
22. Nylander K, Dabelsteen E, Hall PA (2000). The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29: 413-425.
23. Oijen MGCT, Craats JGV, Slootweg PJ (1999). p53 overexpression in oral mucosa in relation to smoking. J Pathol 187: 469-474.
24. Otsubo H, Yokoe H, Miya T et al (1997). Gingival squamous cell carcinoma in a patient with chronic graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Oral Endod 84: 171-174.
25. Prives C, Hall PA (1999). The p53 pathway. J Pathol 187: 112-126.
26. Raybaud-Diogène H, Tétu B, Morency R et al (1996). P53 overexpression in head and neck squamous cell carcinoma: review of the literature. Oral Oncology 32B: 143-149.
27. Schubert MM, Peterson DE, Lloid ME (1999). Oral Complications. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic cell transplantation, 2nd edn. Blackwell Science: London, pp. 751-775.
28. Souza LN, Carneiro MA, Azevedo WM et al (2004). Vascular endothelial growth factor (VEGF) and chronic graft-versus-host disease (cGVHD) in salivary glands of bone marrow transplant (BMT) recipients. J Oral Pathol Med 33: 13-16.
29. Storn R, Thomas ED (1983). Allogeneic bone-marrow transplantation. Immunol Rev 71: 77-102.
30. Sullivan KM (1986). Acute and chronic graft-versus-host disease in man. Int J Cell Cloning 4: 42-93.
31. Zhang L, Epstein JB, Poh CF et al (2002). Comparison of HPV infection, p53 mutation and allelic losses in posttransplant and non-posttransplant oral squamous cell carcinomas. J Oral Pathol Med 31: 134-141.